Eating disorders

Psilocybin as a Treatment for Anorexia Nervosa

Type

In person

Age

21-65

Location

London

Time commitment

Before participants can take part in the study they will undergo three telephone screening calls (~1 hour each) and an in-person screening visit at Imperial College London (~5 hours). In the weeks before the first psilocybin dosing session participants will have multiple preparation calls with the study team. Participants must be available for in-person study visits on Wednesdays, Thursdays, and Fridays.

Study visit 1 (Wednesday ~7-8 hours): EEG brain recording, MRI brain recording, in-person preparation session, questionnaires
Study visit 2 (Thursday ~8 hours): First psilocybin dosing session, questionnaires
Study visit 3 (Friday ~4-5 hours): Integration session and EEG brain recording, questionnaires
Study visit 4 (Thursday ~8 hours): Second psilocybin dosing session, questionnaires (remote telephone preparation session one day before)
Study visit 5 (Friday ~4-5 hours): Integration session and EEG brain recording, questionnaires
Study visit 6 (Thursday ~ 8 hours): Third psilocybin dosing session, questionnaires (remote telephone preparation session one day before)
Study visit 7 (Friday ~4-5 hours): Integration session and EEG brain recording, questionnaires
Study visit 8 (Friday ~6-7 hours): Final follow-up session involving EEG brain recording, MRI brain recording, and final integration session, questionnaires

Participants will be expected to complete online surveys before, during and after the 6-week period of the study. There will also be surveys to complete monthly for 6 months after the follow-up visit, and then a final survey at 12 months. These surveys can take up to 1 hour to complete.

Rewards and expenses

The cost of travel expenses will be covered. Overnight onsite accommodation around dosing days will be available. Participants will not be paid.

About the study

Anorexia nervosa is a life-threatening condition for which there is no pharmacological treatment. There is growing evidence for the therapeutic use of psychedelic drugs such as psilocybin in mental health. This study aims to assess the feasibility and effectiveness of treating anorexia nervosa with psilocybin-assisted therapy. We would also like to gain more understanding of the brain mechanisms that may be involved to this treatment.

What will it involve?

Over a 6-week period, participants will receive three doses of psilocybin (up to 25 mg) in a therapeutic environment, each separated by two weeks. A final follow-up visit will be conducted two weeks after the final dosing session. There will be an extended remote follow-up period of 12-months.

Please note: The inclusion criteria below is not complete. For more information on the study, to view the full inclusion/exclusion criteria, and register to interest in this study please see the self-referral form here: https://imperial.eu.qualtrics.com/jfe/form/SV_2aXw4kjlXmWtC4J

This study is no longer accepting applications